Evidence map›Paper›PMID 37649728›Full record

ArticleKidney medicine2023

Hospitalizations Among Adults With CKD in Public Renal Specialty Practices: A Retrospective Study From Queensland, Australia.

Vishal Diwan, Wendy E Hoy, Zaimin Wang, Jianzhen Zhang, Anne Cameron, Sree K Venuthurupalli, Robert G Fassett, Samuel Chan, Helen G Healy, Ken-Soon Tan and 18 more

Open access · goldAbstract read
In one paragraph

Article in Kidney medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 16 institutions in 2 countries.

Vishal DiwanNHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
Wendy E HoyNHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
Zaimin WangNHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
Jianzhen ZhangNHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
Anne CameronNHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
Sree K VenuthurupalliNHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
Robert G FassettTasmanian Health Service Northwest, Hobart, Tasmania, Australia.
Samuel ChanFaculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Helen G HealyNHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
Ken-Soon TanDepartment of Nephrology, Logan Hospital, Logan, Queensland, Australia.
Richard BaerDepartment of Nephrology, Logan Hospital, Logan, Queensland, Australia.
Andrew J MallettFaculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Nicholas GrayRenal Medicine, Sunshine Coast University Hospital, Sunshine Coast, Queensland, Australia.
Murty ManthaNephrology, Cairns Private Hospital, Cairns, Queensland, Australia.
Roy CherianNephrology Service, North Mackay, Mackay, Queensland, Australia.
Clyson MutatiriRenal Unit, Bundaberg Hospital, Wide Bay Hospital and Health Service, Bundaberg, Queensland, Australia.
Krishan MadhanRenal Medicine, Hervey Bay Hospital, Hervey Bay, Queensland, Australia.
George KanRenal Unit, The Townsville Hospital, Townsville, Queensland, Australia.
Geoffrey MitchellFaculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Shahadat HossainBundaberg Hospital, Bundaberg Central, Queensland, Australia.
Danielle WuMackay Base Hospital, Mackay HHS, Mackay, Queensland, Australia.
Thin HanRockhampton Hospital, Central Queensland HHS, Rockhampton, Queensland, Australia.
Adrian KarkKidney Health Service, Metro North Hospital and Health Service, Brisbane, Queensland, Australia.
Thomas TitusGold Coast University Hospital, Gold Coast, Queensland, Australia.
Dwarakanatan RanganathanSchool of Medicine and Dentistry, Griffith University, Gold Coast, Queensland, Australia.
Ann BonnerNHMRC CKD.CRE and CKD.QLD, Brisbane, Queensland, Australia.
Sridevi GovindarajuluSt Andrew's Hospital, Toowoomba, Queensland, Australia.
NHMRC CKD.CRE and the CKD.QLD Collaborative
The University of Queensland · AUNational Health and Medical Research Council · AUIndigenous Wellbeing Centre · AULogan Hospital · AUMackay Base Hospital · AUQueensland Health · AUCairns Hospital · AUGold Coast Hospital · AUGriffith University · AUHershey (United States) · USIpswich Hospital · AUJames Cook University · AUQueensland Centre for Mental Health Research · AUSt Andrew’s Hospital · AUSunshine Coast University Hospital · AUTownsville Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rationale & Objective: Little is known about hospital admissions in nondialysis patients with chronic kidney disease (CKD) before death or starting kidney replacement therapy (KRT). Study Design: Retrospective observational cohort study. Setting & Participants: Hospitalizations among 7,201 patients with CKD from 10 public renal clinics in Queensland (QLD), enrolled in the CKD.QLD registry starting in May 2011, were followed for 25,496.34 person-years until they started receiving KRT or died, or until June 30, 2018. Predictors: Demographic and clinical characteristics of patients with CKD. Outcomes: Hospital admissions. Analytical Approach: We evaluated the association of demographic and clinical features with hospitalizations, length of hospital stay, and cost. Results: Approximately 81.5% of the patients were admitted at least once, with 42,283 admissions, costing Australian dollars (AUD) 231 million. The average number of admissions per person-year was 1.7, and the cost was AUD 9,060, 10 times and 2 times their Australian averages, respectively. Single (1-day) admissions constituted 59.2% of all the hospital episodes, led by neoplasms (largely chemotherapy), anemia, CKD-related conditions and eye conditions (largely cataract extractions), but only 14.8% of the total costs. Approximately 41% of admissions were >1-day admissions, constituting 85.2% of the total costs, with cardiovascular conditions, respiratory conditions, CKD-related conditions, and injuries, fractures, or poisoning being the dominant causes. Readmission within 30 days of discharge constituted >42% of the admissions and 46.8% costs. Admissions not directly related to CKD constituted 90% of the admissions and costs. More than 40% of the admissions and costs were through the emergency department. Approximately 19% of the hospitalized patients and 27% of the admissions did not have kidney disease mentioned as either principal or associate causes. Limitations: Variable follow-up times because of different dates of consent. Conclusions: The hospital burden of patients with CKD is mainly driven by complex multiday admissions and readmissions involving comorbid conditions, which may not be directly related to their CKD. Strategies to prevent these complex admissions and readmissions should minimize hospital costs and outcomes. Plain-Language Summary: We analyzed primary causes, types, and costs of hospitalizations among 7,201 patients with chronic kidney disease (CKD) from renal speciality clinics across Queensland, Australia, over an average follow-up of 3.54 years. The average annual cost per person was $9,060, and was the highest in those with more advanced CKD, higher age, and with diabetes. More than 85% of costs were driven by more complex hospitalizations with longer length of stay. Cardiovascular disease was the single largest contributor for hospitalizations, length of hospital stay, and total costs. Readmission within 30 days of discharge, particularly for the same disorder, and multiday admissions should be the main targets for mitigation of hospital costs in this population.

Indexed as

Chronic kidney diseaseemergency admissionsepidemiologyhospital admissionskidney replacement therapyreadmissions

Identifiers

PMID37649728
PMCPMC10462882
OpenAlexW4385283446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.